Form 4: Zoetis Director Acquires Phantom Stock Units

Zoetis Inc. Director Mark Stetter acquired 215.5358 phantom stock units through a deferred compensation plan.

Summary

• Mark Stetter, a Director at Zoetis Inc., acquired 215.5358 phantom stock units on March 19, 2026.
• The acquisition was made at a price of $115.99 per unit.
• These units were obtained pursuant to the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan.
• The phantom stock units represent deferred cash retainer fees invested in the Zoetis stock fund, including dividend equivalents.
• Each phantom stock unit is equivalent to one share of Zoetis Inc. common stock.
• The units will be settled in cash following Mr. Stetter's separation from service.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director's acquisition of company equity, even through a deferred compensation plan, generally indicates confidence in the company's long-term value.

Positives

• Director Mark Stetter's acquisition of phantom stock units indicates continued alignment of interests with shareholders.
• The use of a deferred compensation plan suggests a long-term commitment to the company's performance.

Future Outlook

This filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider acquisitions, even through deferred compensation plans, can signal management's confidence in the company's future prospects within the animal health industry. This type of compensation structure is common for non-employee directors to align their interests with long-term shareholder value.

Comparison to Industry Standards

• Deferred compensation plans for non-employee directors, including phantom stock units, are a standard practice across many industries, including pharmaceuticals and animal health, to attract and retain qualified board members.
• Companies like Elanco Animal Health (ELAN) and IDEXX Laboratories (IDXX) also utilize various forms of equity-based compensation for their directors to foster alignment with shareholder interests.

Corporate Governance

Stakeholder Impact

• Shareholders: Potentially positive, as it signals director confidence and aligns interests.
• Employees: No direct impact mentioned.

Next Steps

• The phantom stock units will be settled in cash following Mr. Stetter's separation from service.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction where a director acquired phantom stock units as part of a deferred compensation plan. While it indicates director confidence, it does not present new fundamental information that would warrant a change in investment thesis. Therefore, a "hold" recommendation is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

Zoetis, ZTS, Form 4, Insider Transaction, Phantom Stock Units, Director Compensation, Deferred Compensation, Stock Acquisition